Bioethics(BOTH)
$1.250.00 (0.00%)
BOTH
Bioethics financials statements
$1.25
At close:0.00 (0.00%)
Bioethics (BOTH) Income Statement
12 Followers
Bioethics Income Statement
Last quarter (Q4 2024), Bioethics's total revenue was $0.00. In Q4, Bioethics's net income was $-48.29K. See Bioethics’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 |
|---|---|---|---|---|---|
| $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | |
| $ 0.00 | $ 0.00 | $ 0.00 | $ -226.00 | $ -286.00 | |
| $ 122.82K | $ 50.44K | $ 47.30K | $ 59.37K | $ 75.14K | |
| Depreciation and Amortization | $ 122.82K | $ 50.44K | $ 226.00 | $ 226.00 | $ 286.00 |
| $ 0.00 | $ 0.00 | $ -47.08K | $ -59.14K | $ -74.86K | |
| $ -122.82K | $ -50.44K | $ -47.30K | $ -59.37K | $ -75.14K | |
| $ -54.14K | $ -46.71K | $ -45.90K | $ -47.82K | $ -44.05K | |
| $ -176.96K | $ -97.15K | $ -93.20K | $ -107.18K | $ -119.19K | |
| $ -176.96K | $ -97.15K | $ -93.20K | $ -107.18K | $ -119.19K | |
| Per Share Metrics | |||||
| Basic EPS | $ -0.12 | $ -0.09 | $ -0.08 | $ -0.09 | $ -0.10 |
| Diluted EPS | $ -0.12 | $ -0.09 | $ -0.08 | $ -0.09 | $ -0.10 |
| Weighted Average Shares Outstanding | 1.49M | 1.14M | 1.14M | 1.14M | 1.14M |
| Weighted Average Shares Outstanding (Diluted) | 1.49M | 1.14M | 1.14M | 1.14M | 1.14M |
Currency in USD
